FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry and medicine, namely to production of medicinal preparations for treating hypercholesteremia, atherosclerosis, lipid storage disease. 4 versions of pharmaceutical composition are proposed. According to 2 versions pharmaceutical composition contains calcium rosuvastatin in amount of 5 mg or 10, 20 or 40 mg and as auxiliary substances it has microcrystalline cellulose, mannitol, calcium dihydrophosphate, corn starch, talc, magnesium stearate. According to other 2 versions pharmaceutical composition contains calcium rosuvastatin in amount of 5 mg or 10, 20 or 40 mg and as auxiliary substances it has microcrystalline cellulose, mannitol, crospovidone, talc, magnesium stearate. Pharmaceutical composition is presented in form of tablet, film-coated, or in form of capsules.
EFFECT: invention widens range of drugs for treating lipid storage disease, atherosclerosis, hypercholesterinemia.
20 cl, 14 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING DESLORATADINE (VERSIONS) | 2013 |
|
RU2537169C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING RABEPRAZOLE AND METHOD FOR PRODUCING IT | 2014 |
|
RU2554735C1 |
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| HYPOLIPIDEMIC DOSAGE FORM AND METHOD FOR PREPARING IT | 2013 |
|
RU2547574C2 |
| COMPOSITION AND METHOD FOR PRODUCING A SOLID DOSAGE FORM CONTAINING (Z)-3-(2-OXO-2-(4-TOLYL)ETHYLIDENE)PIPERAZIN-2-ONE | 2017 |
|
RU2657526C1 |
| TWO-LAYER TABLET COMPOSITION | 2020 |
|
RU2824129C2 |
| PHARMACEUTICAL COMPOSITION OF CYCLOBENZAPRINE AND ITS USE | 2022 |
|
RU2794957C1 |
| DOUBLE-LAYER TABLET COMPOSITION | 2010 |
|
RU2712757C2 |
| AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
